Filing Flows › LifeStance Health Group (LFST) › Q3 2026
LifeStance Health Group (LFST) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
LifeStance Health Group (LFST) reported revenue of $456M for the third quarter 2026 (Q3 2026), +25% from a year earlier and +5% from the quarter before. Operating margin was 7.3%, net earnings $22.4M (4.9% of revenue).
LifeStance Health Group, Q3 2026: revenue $456M (+25% year over year), operating margin 7.3%, net earnings $22.4M, operating cash flow $37.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $456M | +5% | +25% |
| Operating profit | $33.1M | +8% | +346% |
| Net earnings | $22.4M | -5% | 21× |
| Operating cash flow | $37.0M | -63% | +36% |
| Free cash flow | $22.4M | -75% | +32% |
What changed
Revenue was $455.9M in Q3 2026, up 25% year over year and up 5% from the previous quarter.
Operating profit was $33.1M, a 7.3% margin (up 5.2 points year over year). Of the extra revenue versus Q3 2025, 28% reached operating profit, above the 2% margin then. Total costs grew 19% against revenue growth of 25%. The fastest-growing cost line was Other operating costs (+19%). Net earnings were $22.4M, up 1978% year over year. The effective tax rate was 18.3%.
Operating cash flow was $37.0M (up 36% year over year), 165% of net earnings. Non-cash charges added back $12.1M of depreciation and amortization and $18.2M of share-based compensation. Working capital and other items used $15.6M. Capital expenditures of $14.7M left free cash flow of $22.4M.
Questions
What was LifeStance Health Group's revenue in the third quarter 2026?
LifeStance Health Group (LFST) reported revenue of $456M for the third quarter 2026 (Q3 2026), +25% from a year earlier and +5% from the quarter before.
Was LifeStance Health Group profitable in the third quarter 2026?
Operating profit was $33.1M (7.3% of revenue) and net earnings $22.4M.